Ativa logo — Decoding Blood, Changing Care.

Ativa

Decoding Blood, Changing Care.

Founded 2008 United States St. Paul, United States 20 employees Venture round Total: $36.23M Biotechnology, Health Care

General Information

Company Name Ativa
Founded Year 2008
Location United States St. Paul, United States
Founders / Decision Makers
Team member
Employees 20
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Ativa. To contact Ativa, visit ativamed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ativa compare?

A PDF of Ativa and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ativa soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ativa

Ativa is a biotechnology and health care startup that aims to revolutionize diagnostic testing with their groundbreaking technology. Founded in 2008 and based in the United States, Ativa's slogan "Decoding Blood, Changing Care" encapsulates their mission to make diagnostic test results available in moments, rather than hours and days. Ativa's innovative system enables nurses and assistants to conduct major critical blood and urine tests on-site, by utilizing a card reader as thin as just a few hairs. This eliminates the need for time-consuming and costly "send outs" to other labs, as it only requires a mere drop of blood. Moreover, while there are existing point-of-care tests in the market, Ativa's product stands out for its capability to conduct all the major tests on-site. With more than 200 patents and a universal operating system, Ativa's technology replicates the most important diagnostic lab tests right at the point of care. Notably, the company received a significant $9.50M Venture Round investment on 07 July 2017. The absence of specific information about the investors indicates the possibility of a confidential or undisclosed investment, reflecting the potential interest and confidence in Ativa's disruptive approach to diagnostic testing. With its impactful technology and promising investments, Ativa is well-positioned to make a substantial impact in the biotechnology and healthcare industries.

Business keywords: Diagnostics, Point of Care, Microfluidics, Hematology, Medical Technology, Healthcare Innovation, Diagnostic Testing, Medical Device Manufacturing, Innovation, Blood Testing, Biomedical Engineering

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $9.50M -
07 Jul 2017
Debt Financing $8.20M -
17 Sep 2015
Series B $15.00M 7
Ping An Ventures, LabCorp +5
17 Sep 2015
Debt Financing $165.00K -
22 May 2013
Series A $3.37M -
26 Jul 2012
Seed Round Undisclosed 1
Twin Cities Angels
15 Feb 2010

Ativa Alternatives & Competitors

View All Alternatives
Ativa vs

Taking Point-of-Care testing to the next level.

Grant
11 employees
Biotechnology, Health Care
Ativa vs
Truvian
Truvian United States

blood testing anyone. anywhere.

Venture round
108 employees
Biotechnology, Health Care
Ativa vs

Achira is a technology company building innovative products for point-of-care medical testing using...

54 employees
Biotechnology, Health Care

FAQ About Ativa

Decoding Blood, Changing Care.
Ativa was founded in 2008.
Ativa is headquartered in St. Paul, United States.
Ativa operates in Biotechnology and Health Care. Its work centres on Diagnostics, Point of Care, Microfluidics and Hematology.
Ativa has approximately 20 employees.
Ativa has completed 6 funding rounds, raising a total of $36.23M. The latest funding stage is Venture round.
Top alternatives and competitors to Ativa include FRIZ Biochem GmbH, Truvian, Achira Labs Pvt. Ltd., Haemokinesis, In Vitro Diagnostic Solutions (IVDS). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ativa and FRIZ Biochem GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ativa, https://bouncewatch.com/company/ativa, updated 11 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes